830 related articles for article (PubMed ID: 8603832)
1. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
Rumble JR; Doyle AE; Cooper ME
Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098
[TBL] [Abstract][Full Text] [Related]
3. Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
Cooper ME; Rumble JR; Gin T; Lim-Joon T
Clin Exp Pharmacol Physiol Suppl; 1992; 19():23-7. PubMed ID: 1395113
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hypertension abrogates early inflammatory events in the retina of diabetic hypertensive rats.
Silva KC; Pinto CC; Biswas SK; Souza DS; de Faria JB; de Faria JM
Exp Eye Res; 2007 Jul; 85(1):123-9. PubMed ID: 17493613
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effects of perindopril treatment in adult spontaneously hypertensive rats.
Lee RM; Lu M; Gillies L; Werstiuk ES
Can J Cardiol; 1997 Sep; 13(9):831-5. PubMed ID: 9343032
[TBL] [Abstract][Full Text] [Related]
7. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
[TBL] [Abstract][Full Text] [Related]
8. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
9. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
Christensen KL; Jespersen LT; Mulvany MJ
J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
[TBL] [Abstract][Full Text] [Related]
10. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF
J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
Cooper ME; Rumble JR; Allen TJ; O'Brien RC; Jerums G; Doyle AE
Kidney Int; 1992 Apr; 41(4):898-903. PubMed ID: 1513111
[TBL] [Abstract][Full Text] [Related]
12. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
[TBL] [Abstract][Full Text] [Related]
13. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
14. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
15. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
O'Brien RC; Cooper ME; Jerums G; Doyle AE
Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
[TBL] [Abstract][Full Text] [Related]
16. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
17. Interaction between an angiotensin converting enzyme inhibitor, perindopril, and a thiazide diuretic in the spontaneously hypertensive rat.
Scalbert E; Abdon D; Devissaguet M; Juggi JS
Can J Cardiol; 1992 May; 8(4):381-6. PubMed ID: 1617521
[TBL] [Abstract][Full Text] [Related]
18. Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
Emonnot L; Cohen R; Lo M
Am J Hypertens; 2008 Jun; 21(6):657-62. PubMed ID: 18443571
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive treatment in spontaneously hypertensive rats with streptozotocin-induced diabetes mellitus.
Kusaka-Nakamura M; Kishi K; Miyazawa A; Yagi S; Sokabe H
Acta Physiol Hung; 1988; 71(2):251-69. PubMed ID: 3291554
[TBL] [Abstract][Full Text] [Related]
20. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
